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Abstract
Background: Extracellular matrix metalloproteinase inducer (EMMPRIN) regulates several biological functions 
involving the modulation of cell behaviors via cell-cell and cell-matrix interactions. According to its diverse functions, 
we hypothesized that EMMPRIN may play an important role in endometrial remodeling and establishment of 
pregnancy in cow.
Methods: In this study, endometrial tissues from the cyclic cows during before ovulation, after ovulation and middle of 
estrous cycle; and pregnant endometrial tissues from Day 19 to 35 of gestation have been used. Expression of mRNA 
was analyzed by RT-PCR, qPCR and in situ hybridization whereas protein expression by immunohistochemistry and 
western blot analysis.
Results: EMMPRIN mRNA was expressed in both cyclic and pregnant endometrium and significantly higher in the 
endometrium at Day 35 of gestation than the cyclic endometrium. In Western blot analysis, an approximately 65 kDa 
band was detected in the endometrium, and approximately 51 kDa in the cultured bovine epithelial cells and BT-1 
cells, respectively. Both in situ hybridization and immunohistochemistry data showed that EMMPRIN was primarily 
expressed in luminal and glandular epithelium with strong staining on Day 19 conceptus. At Day 19 of gestation, 
expression of EMMPRIN mRNA on luminal epithelium was decreased than that observed at middle of estrous cycle, 
however, on Day 30 of gestation, slightly increased expression was found at the site of placentation. Expression of 
matrix metalloproteinase-2 (MMP-2) and MMP-14 mRNA were mainly detected in stroma and their expression also 
decreased at Day 19 of gestation however it was also expressed at the site of placentation at Day 30 of gestation as 
observed for EMMPRIN. Expression of MMP-1 or -9 mRNA was very low and was below the detection limit in the cyclic 
and pregnant endometrium.
Conclusion: EMMPRIN from the luminal epithelium may regulate the expression of stromal MMP-2 and -14 suggesting 
its crucial role in adhesion and fusion of embryo to luminal epithelium by directly itself through physiological tissues 
remodeling and developmental process, and/or stimulating MMPs to compensate endometrial functions.
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Background
The bovine endometrium is a highly complex and
dynamic tissue composed of the caruncular endome-
trium, which acts as the implantation site and consists of
a thickened subepithelial stroma, and another region
termed the intercaruncular endometrium located
between the caruncles containing glandular regions [1].
There are certain requirements for successful implanta-
tion in ruminants. Firstly, the endometrium needs to be
prepared for this event during the estrous cycle, and
especially around implantation; and secondly, the tropho-
blast must be able to fuse with the endometrial epithe-
lium in the caruncle region. In this regard, endometrial
remodeling during the estrous cycle and early gestation
remains crucial for the establishment of pregnancy. In
human, sloughing of the functional layer of the endome-
trium and subsequent healing occur, which are highly
regulated by matrix metalloproteinases (MMP) [2,3];
however, this phenomenon does not occur in ruminants,
although the endometrium undergoes dynamic changes
in its mRNA profile accompanied by morphological
changes during the estrous cycle [4,5]. During the estrous
cycle and the establishment of pregnancy, endometrial
cells undergo rapid growth and differentiation, extracel-
lular matrix (ECM) break down and remodeling [6,7].
Around implantation, a number of molecules are
expressed at the embryo-maternal interface including
interferon-tau, cytokines, growth factors, hormones, and
MMP [8-11]. These changes in the endometrium are
partly modulated by the expression of the MMP system
[12-14], a disintegrin and metalloproteinase with throm-
bospondin motif (ADAMTS)-1 [15,16], and extracellular
matrix metalloproteinase inducer (EMMPRIN) [17] in
coordination with ovarian steroids [18,19].
EMMPRIN (also known as Basigin or CD147) is a mul-
tidomains, multifunctional glycoprotein located on the
cell surface in physiological and pathological conditions
including tumor cells [20-24]. EMMPRIN is associated
with cell growth and adhesion [25], angiogenesis [26,27],
chaperone functions [28,29], immune cell activation [30],
proMMP-1 activation [31], MMP induction [32,33], and
ECM degradation and remodeling [34]. EMMPRIN is
highly associated with the menstrual cycle [35,36],
estrous cycle, and pregnancy in mice [17] and rats [37], as
well as ovulation and luteogenesis [38]. In cow, EMM-
PRIN may be involved in endometrial remodeling for
implantation same as those in other species because
recent reports showed that MMP and ECM-related mole-
cules including EMMPRIN expressed in bovine endome-
trium and placenta [10,14]. These previous reports
strongly suggest that EMMPRIN takes a vigorous role for
implantation process in various species irrespectively.
However, the expression of EMMPRIN and its role in
implantation are still obscure in cow. At present, there
has been no report on the expression and role of EMM-
PRIN in the bovine endometrium. Therefore, the aim of
our study was to examine the expression and cellular
localization of EMMPRIN along with MMP-1, -2, -9 and -
14 in the bovine endometrium during the estrous cycle
and early gestation, secondly, how EMMPRIN regulates
MMPs at the feto-maternal interface during this critical
period.
Methods
Animals and tissue collection
Endometrial tissues were collected from Japanese Black
cows at different functional stages of estrous cycle and
early gestation for RT-PCR, quantitative RT-PCR (qPCR),
in situ hybridization, Western blotting and immunohis-
tochemistry according to the objectives of this study. The
physiological status of the cyclic endometrial tissues was
estimated based on ovarian morphology as described
previously [39]. Namely, the approximate day of the
estrous cycle was determined in four distinct sequential
stages by the appearance of the corpus luteum and the
size of the follicles: stage I - days 1 to 4; stage II - days 5 to
10; stage III - days 11 to 17; stage IV-days 18 to 20. In the
present study, we reorganized the estrous cycle into three
stages as follows: stage after ovulation (AOV) - days 1 to 4
(n = 3), middle of estrous cycle (MEC) stage - days 5 to 17
(n = 3), and stage before ovulation (BOV) - days 18 to 20
(n = 3). Pregnant tissues were collected during the peri-
implantation period, Day 19 (totally n = 3, two cows on
day 19 and one cow on day 20) and post implantation
period; Day 30 (totally n = 3, including one cow on day 28
and two cows on day 30) and Day 35 (totally n = 3, two
cows on day 35 and one cow on day 37). Pregnancy was
derived by artificial insemination (AI) (the day of insemi-
nation was designated as Day 0 of gestation). Histological
studies were performed using endometrium from estrous
cycle (BOV, AOV, MEC), and Day 19 and Day 30 of gesta-
tion. These tissues were fixed in 4% paraformaldehyde-
phosphate buffered saline (PBS, pH 7.4) and stored at
4°C. Some pregnant uteri were perfused with 4% (w/v)
paraformaldehyde PBS on early gestation and all tissues
for histological examination were managed according to
the previous report [40]. RT-PCR and Western blot anal-
ysis were done using middle of estrous cycle. qPCR was
performed using cyclic endometrial tissues and Day 35 of
pregnant endometrial and fetal tissues. Briefly, immedi-
ately after collection, all tissues were snap frozen in liquid
nitrogen and stored at -80°C until RNA extraction. Some
uterine tissues were collected for histological studies as
mentioned above. All animal procedures were carried out
in accordance with the guidelines and ethics set out by
the Animal Care and Use Committee of the Iwate Univer-
sity and the National Institute of Agrobiological Sciences,
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RNA extraction and RT-PCR
Total RNA was individually isolated using TRIzol (Invit-
rogen, Carlsbad, CA, USA) according to the manufac-
turer's instructions. The yield of total RNA was
quantified by measuring the absorbance at 260 nm
(A260). RNA quality was determined by measuring the
A260/A280 ratio using a NanoDrop Spectrophotometer
(ND-1000, Wilmington, DE, USA) and by 1% agarose gel
electrophoresis. Two micrograms of total RNA was
reverse transcribed into cDNA using random primers
with a high capacity reverse transcriptase kit (Applied
Biosystems, Foster City, CA, USA) according to the man-
ufacturer's instructions. The RT cycle comprised 25°C for
10 minutes, 37°C for 120 minutes, and 85°C for 5 seconds
in the thermal cycler, and cDNA were stored at -20°C.
The PCR primers were designed using the Primer-3 soft-
ware [41] based on bovine sequences (Table 1). The PCR
reaction was performed at 95°C for 30 seconds for dena-
turing, 60°C for 30 seconds for annealing, and at 72°C for
1 minute for extension and was repeated for 30 cycles.
The PCR products were subjected to electrophoresis
using 2% gel and stained with ethidium bromide solution.
The amplified products were sub-cloned into the pGEM-
T Easy vector (Promega, Madison, WI, USA) and
sequenced using the Big dye terminator cycle sequencing
kit and an automated sequencer (Applied Biosystems).
Quantitative real-time RT-PCR (qPCR)
The gene expression of EMMPRIN, MMP-1, -2, -9, and -
14 was confirmed at each stage of the estrous cycle and
Day 35 of gestation by qPCR using the SYBR Green assay
(Applied Biosystems) as described previously [42]. In the
SYBR Green assay, primer pairs were designed using the
Primer Express software program (Applied Biosystems)
(Table 2). The standard curves for each gene were gener-
ated by serial dilution of a plasmid containing EMM-
PRIN, MMP-1, -2, -9, and -14 cDNA in order to quantify
the mRNA concentrations. We confirmed the melting
curve for detecting the SYBR Green-based objective
amplicon because SYBR Green also detects double-
stranded DNA including primer dimers, contaminating
DNA, and PCR products from misannealed primers.
Contaminating DNA or primer dimers appear as peaks
separate from the desired amplicon peak. The expression
ratio of each gene to GAPDH mRNA was calculated to
adjust for variations in the RT-PCR reaction.
In situ hybridization analysis
The bovine cDNA were used as templates for hybridiza-
tion probe synthesis. Digoxigenin (DIG)-labelled anti-
sense and sense-complementary RNA probes were
prepared using DIG RNA labelling kits (Roche, Diagnos-
tic GmbH, Mannheim, Germany) and cloned cDNA in
plasmids as described previously [42]. Formalin-fixed tis-
sue was positioned for paraffin embedding using the
methods described previously [42]. Briefly, the tissues
were treated with a series of alcohols (from 70% to abso-
lute alcohol), xylene, and paraffin. The endometrial tis-
sues were then cut into 7 μm-thick sections, and in situ
hybridization was performed using an automated Ven-
t a n a  H X  S y s t e m  D i s c o v e r y  w i t h  a  R i b o M a p K i t  a n d  a
BlueMapKit (Ventana, Tucson, AZ, USA). Briefly, the
sections were hybridized with DIG-labelled probes in
RiboHybe (Ventana) hybridization solution at 61°C for
EMMPRIN, MMP-1, -2, -9, and -14 for 6 hours, before
being washed 3 times for 6 minutes in RiboWash (Ven-
tana) at 65°C and fixed in RiboFix (Ventana) at 37°C for
10 min. The hybridization signal of each gene was
detected using rabbit monoclonal anti-digoxin biotin
conjugates (Sigma, Saint Louis, MO, USA) and an Amp-
MapKit (Roche/Ventana). Counterstaining was per-
formed with nuclear fast red (Roche/Ventana). After
Table 1: Oligonucleotide primers used for standard RT-PCR analysis
Gene Primer Sequence Position
EMMPRIN Forward TCCAAAACACGACTCACCTGTG 153-174
(NM_001075371) Reverse GCTTCCGCCTCTTCTCGTAGAT 753-732
MMP-1 Forward TGCTCATGCTTTTCAACCAG 554-574
(NM_174112) Reverse TCCGGGAAAGTCTTCTGCTA 1274-1254
MMP-2 Forward CAGACAGTGGATGATGCCTTCG 596-618
(NM_174745) Reverse GCGGCCTGTGTCTGTGCAGC 940-920
MMP-9 Forward TGGACATCTTCGACGCCATC 1574-1593
(NM_174174) Reverse CGAACCTCCAGAAGGTCTGC 1927-1908
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preparation, the hybridized slides were observed with a
Leica DMRE HC microscope (Leica Microsystems, Wet-
zlar, Germany) equipped with a DS-Fi1 camera and a DS-
L2 control unit (Nikon, Tokyo, Japan).
Immunohistochemistry
For immunohistochemical analysis of EMMPRIN, forma-
lin fixed and paraffin embedded endometrial tissues were
cut into 7 μm-thick sections as mentioned for the in situ
hybridization. Briefly, the sections were permeabilized
with proteinase K and incubated with a primary EMM-
PRIN antibody at a dilution of 1:1000 in antibody diluents
(Ventana). The rabbit polyclonal anti-human EMMPRIN
antibody was developed using three different synthetic
peptides, EM1: 42SLNDSATEVTGHRWLK57, EM6:
138AWYKITDSEDKALMN152, and EM9:
170HIENLNMEADPGQYR184. Anti-EM6 antibody, the
amino acid sequence of which exists in the second loop
domain of human EMMPRIN (Accession number:
AB072923) [20] was used in the present study because all
three antisera recognized EMMPRIN molecules in SKGII
cell lysates but other two antisera recognized some extra
bands. Antiserum was further purified by affinity chro-
matography, and then the affinity-purified antibody was
used for immunohistochemistry and Western blot analy-
sis [43].
The sections were then washed and incubated with an
anti-rabbit IgG-Biotin conjugate (Sigma) for 1 hour.
Immunoreactive signals were detected using streptavi-
din-horseradish peroxidase (HRP) and diaminobenzidine
(DabMapKit, Ventana). In the controls, the normal rabbit
sera (NRS; DAKO, CA, USA) were used. Counterstaining
was then performed with haematoxylin and bluing
reagent (saturated lithium carbonate solution). After
treatment, the sections were observed under a micro-
scope equipped as described above.
Western blotting for EMMPRIN
Western blotting was performed as described previously
[44]. Bovine endometrial tissues during estrous cycle
were homogenized in a lysis buffer containing 50 mM
Tris (pH 7.5), 150 mM NaCl, 0.1% Triton X-100, and the
protease inhibitor cocktail Complete, Mini (Roche Diag-
nostic GmbH). Supernatant of tissues lysate was collected
followed by centrifugation at 15,800 × g for 15 minutes at
4°C. Bovine endometrial stromal cells (BES) [45], epithe-
lial cells (BEE, kindly supplied by Dr. Iga) [46], and tro-
phoblastic cells (BT-1), which were derived from bovine
blastocysts [47], were maintained in DMEM/F12 with
10% fetal bovine serum until full confluence [45]. The
confluenced cells were then washed with serum free
media followed by PBS and homogenized in a lysis buffer.
After centrifugation at 15,800 × g for 15 minutes at 4°C,
the supernatant was collected and preserved for further
analysis. The concentration of total protein of both tis-
sues and cell lysates was analyzed using the Quick Start
Bradford protein assay kit (Bio-Rad Laboratories, Hercu-
les, CA, USA). Human uterine cervical carcinoma SKG-II
cell lysates were used as a positive control [43]. The pro-
teins (28 μg) of each cell lysate were separated by 10%
sodium dodecyl sulfate polyacrylamide gel electrophore-
sis and then transferred to PVDF membranes (Immobi-
lon-P, Millipore Corporation, Bedford, MA, USA). The
membranes were first blocked with 5% skimmed milk and
then treated with rabbit anti-EMMPRIN antibody as
mentioned above at a dilution of 1:1000, before being
incubation with alkaline phosphatase-conjugated goat
anti-rabbit IgG (Sigma). An alkaline phosphatase detec-
Table 2: Oligonucleotide primers used for Real-time RT-PCR analysis
Gene Primer Sequence Position
EMMPRIN Forward CGGAGTATGAGGTGGACTCAGAA 265-288
(NM_001075371) Reverse GCTCCGGAAGGAAGATGCA 327-308
MMP-1 Forward TGGACCAGCAATTTCCAAGAT 618-639
(NM_174112) Reverse TCCAAGGGAATGGCCAAA 686-668
MMP-2 Forward GGAGAGGCTGACATCATGATCA 677-699
(NM_174745) Reverse CCCGTCTTTGCCATCAAAA 751-770
MMP-9 Forward CATTTCTTCAAGGCTGGGAAGTA 1615-1638
(NM_174174) Reverse GCGCAGGCCACTTGCT 1708-1692
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t io n sys t e m  (B io- Rad La bora t o ries)  was used t o det ect
immunoreactive EMMPRIN.
Statistical analysis
All values are presented as the mean ± SEM. qPCR was
duplicated in one animal sample. Statistical analysis was
performed by JMP software (SAS Institute Inc, Cary, NC,
USA) using one-way ANOVA followed by the Turkey-
Kramer test. Different letters indicate significant varia-
tion among the statuses of the tissues.
Results
Expression and localization of EMMPRIN mRNA in the 
bovine endometrium
A partial cDNA for bovine EMMPRIN was amplified by
RT-PCR from endometrial tissue after being isolated in
the middle of the estrous cycle (Figure 1A). A 601 bp
c D N A  f r a g m e n t  w a s  o b t a i n e d  a n d  i d e n t i f i e d  a s  t h e
bovine EMMPRIN sequence (NCBI reference sequence
NM_001075371).
The expression of EMMPRIN mRNA was analyzed by
qPCR during the estrous cycle and at Day 35 of preg-
nancy (Figure 1B). In the cyclic endometrium, EMM-
PRIN mRNA expression was slightly increased after
ovulation and in the middle of the estrous cycle com-
pared with before ovulation and was significantly higher
in the endometrium at Day 35 of gestation. The fetal
membrane at Day 35 of gestation also expressed EMM-
PRIN mRNA but the intensity of expression was slightly
lower than that of the endometrium.
The localization of EMMPRIN mRNA was detected in
the bovine endometrium during the estrous cycle, at Day
19 and 30 of gestation by in situ hybridization analysis
(Figure 2, Table 3). Anti-sense RNA probes (Figure 2A-E)
for EMMPRIN specifically detected mRNA transcripts in
the endometrium, but no significant signals were
detected by sense probes (Figure 2A'-E') at any stage of
the estrous cycle and early gestation. In the endometrium
before ovulation (BOV), EMMPRIN mRNA expression
remained below the detection limit (Figure 2A). After
ovulation (AOV), it was moderately expressed in luminal
epithelium but slightly in stroma and glandular epithe-
lium (Figure 2B); on the other hand, it was strongly
expressed in the luminal and glandular epithelia but
slightly expressed in the stroma in the middle of the
estrous cycle (MEC) (Figure 2C). During early gestation
(Day 19), EMMPRIN mRNA was slightly expressed in the
luminal and glandular epithelia but remained below the
detection limit in the stroma; whereas, strong expression
was found in the conceptus (Figure 2D). At Day 30 of ges-
tation, moderately expressed at the site of placentation
(Figure 2E).
Expression and localization of EMMPRIN protein in the 
bovine endometrium
In Western blot analysis, three immunoreactive bands
were detected with anti-human EMMPRIN antibody in
extracts from the bovine endometrium, cultured bovine
endometrial stromal cells, epithelial cells, and tropho-
blastic cells (BT-1), with human uterine cervical carci-
noma SKG-II cells used as a positive control (Figure 3).
An approximately 65 kDa band was clearly detected and
faint 35 kDa was recognized in the MEC endometrium,
respectively; however, slight expression was detected at
other stages of the estrous cycle (data not shown). On the
other hand, the intense band migrated approximately 51
and 32 kDa in the cultured bovine epithelial cells and BT-
1 cells, respectively; whereas, a 32 kDa band was detected
weakly in the stromal cells.
Figure 1 Expression of EMMPRIN mRNA in the bovine endometri-
um during the estrous cycle and at Day 35 of gestation. Partial 
cDNA was amplified and a 601 bp band was detected as bovine EMM-
PRIN by RT-PCR (A). Quantitative analysis of EMMPRIN mRNA was per-
formed by qPCR and normalized to GAPDH mRNA expression (B). Bar 
graph showing the mean ± SD. Data labeled with different letters are 
significantly different from each other (P < 0.05). bp, base pair; BOV, be-
fore ovulation; AOV, after ovulation; MEC, middle of estrous cycle; D35 
ENDO, endometrium at Day 35 of gestation, D35 FM, fetal membrane 
at Day 35 of gestation.
Table 3: Summary of localization of EMMPRIN mRNA and protein 
expression in the endometrial tissues
Tissues BOV AOV MEC Day 19 Day 30
EMMPRIN Stroma - + + - -
mRNA LE - + + + + + + + +
GE - + + + + + -













BOV, before ovulation; AOV, after ovulation; MEC, middle of estrous 
cycle; Day 19, day 19 of gestation; LE, luminal epithelium; GE, 
glandular epithelium; St, stroma; -, below detection limit; +, slight 
expression; ++, moderate expression; +++, strong expression; -/+++, 
upper stroma is below detection limit and lower stroma has strong 
expression; NA, not analyzedMishra et al. Reproductive Biology and Endocrinology 2010, 8:60
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To confirm EMMPRIN protein localization in the
endometrium, we performed immunohistochemical
analysis (Figure 4, Table 3). Immunoreactive EMMRIN
protein was detected slightly in the stroma, luminal and
glandular epithelia in the endometrium at BOV (Figure
4A); whereas, moderate immunostaining was observed in
the luminal epithelium and stroma but only slight stain-
ing was seen in the glandular epithelium at AOV (Figure
4B). At MEC, strong staining was detected in the luminal
and glandular epithelia but moderate staining was found
in the stroma (Figure 4C). During early gestation (Day
19), moderate staining of EMMPRIN in luminal epithe-
lium, intense staining was detected in the gland and
stroma surrounding the glands and in the conceptus;
whereas, protein signals were absent in the stroma under
the epithelium (Figure 4D).
Expression and localization of gelatinases (MMP-2 and 
MMP-9 mRNA)
Expression of MMP-2 and -9 mRNA were detected in the
endometrium during the estrous cycle and at Day 35 of
gestation by qPCR. MMP-2 mRNA was significantly
higher at after ovulation and decreased at mid-cycle and
Day 35 of gestation; whereas, slight expression was found
in the fetal membrane (Figure 5A). In situ hybridization
data showed that MMP-2 mRNA was below the detection
limit at BOV (Figure 6A), strongly localized in the stroma
AOV (Figure 6B), and moderately during the middle of
the cycle (Figure 6C). At Day 19 of gestation, MMP-2 was
slightly expressed in the stroma (Figure 6D) but moder-
ately at the site of placentation at Day 30 of gestation (Fig-
ure 6E). The expression levels of MMP-9 mRNA was very
low (Figure 5B) whereas its localization remained below
the detection limit at each stage in the cyclic and preg-
nant endometrium (Figure 6F-J). The localization of
MMP-2 and -9 mRNA has summarized in Table 4.
Expression and localization of MMP-1 and MMP-14 mRNA
Expression of MMP-1 and MMP-14 mRNA was detected
in the endometrium during the estrous cycle and at Day
35 of gestation by qPCR. The expression levels of MMP-1
mRNA was very low (Figure 5C) and statistically insignif-
icant whereas its localization remained below the detec-
Figure 2 Localization of EMMPRIN mRNA in the endometrial tis-
sues during the estrous cycle and early gestation. Seven-microm-
eter sections of the endometrium were hybridized with DIG labeled 
antisense cRNA probes (A-E) and sense cRNA probes (A'-E'). A, A': be-
fore ovulation (BOV); B, B': after ovulation (AOV); C, C': middle of estrous 
cycle (MEC); D, D': Day 19 of gestation; E, E': Day 30 of gestation. Super-
imposed figures showed the glandular region. le, luminal epithelium; 
st, stroma; con, conceptus. Scale bar = 20 μm (objective; 20×).
Figure 3 Expression of EMMPRIN protein in the bovine endome-
trial tissues by Western blot analysis. The proteins of bovine endo-
metrial tissues in the middle of the estrous cycle (MEC), endometrial 
stromal cells (BES), epithelial cells (BEE), trophoblastic cells (BT-1), and 
human uterine cervical carcinoma cell (SKG-II) were resolved by SDS-
PAGE. Molecular weight markers are indicated on the left and protein 
bands are shown on the right. Results shown are representative of 
three independent experiments.Mishra et al. Reproductive Biology and Endocrinology 2010, 8:60
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tion limit at each stage in the cyclic and pregnant
endometrium (Figure 7A-E).
Expression of MMP-14 mRNA was significantly higher
at after ovulation and decreased during mid-cycle and at
Day 35 of gestation; whereas, slight expression was found
in the fetal membrane (Figure 5D). MMP-14 mRNA was
slightly localized in stroma before ovulation (Figure 7F)
but was strongly localized in the stroma after ovulation
(Figure 7G) with moderate expression seen during the
MEC (Figure 7H). At Day 19 of gestation, MMP-14
mRNA expression was slight in the stroma and luminal
epithelium (Figure 7I) but moderately expressed at the
site of placentation on the Day 30 of gestation (Figure 7J).
The localization of MMP-1 and MMP-14 mRNA has
summarized in Table 4.
Discussion
The purposes of this study are following: 1) to determine
the expression of EMMPRIN in bovine endometrium
during estrous cycle and early gestation; 2) to find the
localization of its expressive cells; and 3) to explore its
roles in the endometrial remodeling for the receptivity of
embryos in cow. We used a quantitative gene analysis, in
situ hybridization and immunohistochemical methods.
We examined the expression of MMP-1, -2, -9 and -14 as
the indicators for assuming EMMPRIN roles in the
remodeling of endometrium in cow. The present study
reveals the first sequential evidence that EMMPRIN
expresses in bovine endometrium during estrous cycle
and the critical period of implantation. The expression of
EMMPRIN in the bovine endometrium matched roughly
but not completely with that highlighted by the previous
studies of humans and rodents. In human, EMMPRIN is
highly associated with endometrial remodeling during
the menstrual cycle, and it was detected in the luminal
and glandular epithelium and stroma [35,36]. In mice,
EMMPRIN was expressed in the epithelium around
implantation but defects in EMMPRIN expression caused
reproductive failure in KO mice [48]. These results
strongly suggest that EMMPRIN involves in the process
of receptivity in any species like cow, human and rodents.
The expression of bovine EMMPRIN during the estrous
cycle may be closely related to steroid hormone levels in
bovines as in humans and mice [35,48,49]. During the
estrous cycle, EMMPRIN expression was found accord-
ing to cyclic changes in endometrium and was at highest
intensity during the middle of estrous cycle when the cir-
culatory progesterone level is in peak, reflecting the regu-
latory role of progesterone over EMMPRIN as in human
[35]. However, estrogenic effects cannot be neglected in
cow because expression was found during the estrogenic
phase as seen in rodents [17,37].
In the present study, around peri-implantation period,
expression of EMMPRIN in luminal epithelial was
decreased compared to that observed in the middle of the
estrous cycle but ample EMMPRIN was expressed by the
peri-attachment conceptus. Active embryonic and endo-
metrial expressions around implantation have been
reported in mice [17,48]. The reasons for decreased in
epithelial expression of EMMPRIN during this critical
period remained unclear. EMMPRIN also has the poten-
tial for inducing the ECM degradation necessary for bio-
logical functions by itself or by activating neighboring
cells to induce MMP production [34]. In the present
study, in situ hybridization and immunohistochemistry
analysis using tissue materials during peri-implantation
period showed that conceptus expressed EMMPRIN gene
and protein, and MMPs (MMP-2 and -14) were detected
in epithelia and subepithelial stromal area. These data
Figure 4 Localization of EMMPRIN protein in the endometrial tis-
sues throughout the estrous cycle and on Day 19 of gestation ac-
cording to immunohistochemistry analysis. Seven-micrometer 
sections of endometrium were immunostained with anti-EMMPRIN 
antibody (A-D) and normal rabbit serum (A'-D'). A, A': before ovulation 
(BOV); B, B': after ovulation (AOV); C, C': middle of estrous cycle (MEC); 
D, D': Day 19 of gestation. Abbreviations are same as figure 2. Scale bar 
= 20 μm (objective; 20×).Mishra et al. Reproductive Biology and Endocrinology 2010, 8:60
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suggest that EMMPRIN induces MMP production during
this critical period in bovine at feto-maternal interface.
Another important role of EMMPRIN during preg-
nancy may be maintaining of glandular functions,
because the ruminant intercaruncular endometrium con-
tains a large number of uterine glands that synthesize and
secrete or transport a variety of substances necessary for
the survival and development of the conceptus [50,51].
During the early stage of the estrous cycle, the uterine
glands are elongated and coiled and then gradually prolif-
erate and become swollen in order to secrete uterine milk
protein [52]. EMMPRIN expression was well correlated
with glandular development during the estrous cycle. At
Day 19 of gestation, intense staining of EMMPRIN was
found on the stroma surrounding the glands. This
stromal expression might be from the glandular epithe-
lium because EMMPRIN can shed from the surface of
Table 4: Summary of localization of MMP mRNA expression in the endometrial tissues
Gene Tissues BOV AOV MEC Day 19 Day 30
MMP-1 S t r o m a --- - -
L E --- - -
G E --- - -
MMP-2 Stroma - + + + + + + + +
L E --- - +
G E --- - -
MMP-9 S t r o m a --- - -
L E --- - -
G E --- - -
MMP-14 Stroma + + + + + + + + +
LE - - + + + +
G E --- - -
All indicators are same as Table 3
Figure 5 Expression profile of MMP mRNA in the bovine endome-
trium during the estrous cycle and at Day 35 of gestation. Quanti-
tative analysis of MMP mRNA was performed by qPCR and normalized 
to the expression of GAPDH mRNA. MMP-2 mRNA (A), MMP-9 mRNA 
(B), MMP-1 mRNA (C), and MMP-14 mRNA (D). Bar graph showing the 
mean ± SD. Data labeled with different letters are significantly different 
from each other (P < 0.05). Abbreviations are same as Figure 1.
Figure 6 Localization of MMP-2 and MMP-9 mRNA in the endo-
metrial tissues during the estrous cycle and early gestation. Sev-
en-micrometer sections of the endometrium were hybridized with DIG 
labeled antisense cRNA probes of MMP-2 (A-E) and sense cRNA probes 
(A'-E'). A, A': before ovulation (BOV); B, B': after ovulation (AOV); C, C': 
middle of estrous cycle (MEC); D, D': Day 19 of gestation; E, E': Day 30 of 
gestation. MMP-9 mRNA antisense (F-J) and sense cRNA probes (F'-J'). 
F, F': BOV; G, G': AOV; H, H': MEC; I, I': Day 19; J, J': Day 30 of gestation. 
Abbreviations are same as Figure 2. Scale bar = 20 μm (objective; 20×).Mishra et al. Reproductive Biology and Endocrinology 2010, 8:60
http://www.rbej.com/content/8/1/60
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epithelial cells and acts as a diffusible factor, reaching
other cells in vicinity [53]. This epithelio-stromal interac-
tion may leads to stimulation of MMPs in lower stromal
compartment which further activates other cytokines and
growth factors necessary for implantation.
EMMPRIN has been characterized as an important
inducer of MMP in tumor tissues [20,54], but has no
effects on their physiological inhibitors (tissue inhibitor
for MMP-1 and -2; TIMP-1 or -2), therefore modifying
the balance among MMP production and activation.
Membrane type 1-MMP (MT1-MMP as described as
MMP-14 in the present study) cleaves the functional N-
terminal domain of EMMPRIN from the cell surface,
which is expected to down-regulate its function, but at
the same time, the released 22-kDa fragment may medi-
ate the expression of MMP-2 in tumor tissues [55]. In the
present study, we detected some different sized EMM-
PRIN proteins in the endometrial tissues; MEC and three
cultured cells (epithelial cells, stromal cells, and tropho-
blast) by Western blotting as shown in Figure 3, suggest-
ing that the various sizes of EMMPRIN proteins
expressed by bovine endometrial cells may correspond to
the secretory and membrane-binding forms [43,55].
Therefore, the functions and regulation of EMMPRIN
activity during remodeling of the normal endometrium
are still difficult to explain because various factors such as
membrane-type MMP, tissue inhibitor of metalloprotei-
nases, ADAMTS, etc., are involved [14,55]. Despite sig-
nificant research into the induction of MMP by
EMMPRIN, many fundamental questions persist as to
whether the induction of MMP by EMMPRIN is species
specific, tissue specific, or related to the functional status
of tissues. Few possible explanations have been given by
some researchers. EMMPRIN has expressed at all stages
in pre-implantation developing embryos but none of
MMPs, suggests that EMMPRIN may not function as an
MMP inducer in embryos [56]. In a recent report on
adult mammary gland development, EMMPRIN did not
stimulate the induction of MMP [57]. On the other hand,
co-localization of MMP-1 and EMMPRIN was detected
in the endometrium during the menstrual cycle [35],
which was not seen in current study. The stimulation of
MMP production by EMMPRIN via fibroblasts was also
shown previously [54]. Uses of recombinant EMMPRIN
has been shown to increase the expression of various
MMPs in the physiological tissues in dose and time
dependent manner, however it's difficult to explain the
mechanism of such induction.
To show the possibility of EMMPRIN as a player of
MMPs, we examined the expression of MMP-1, -2, -9 and
-14 in the cyclic and pregnant endometrium. EMMPRIN
was primarily expressed on epithelial cells whereas
MMP-2 and -14 were mainly expressed in stromal cells
adjacent to basement membrane. Therefore, we have
expected that EMMPRIN from the epithelial cells may
activate MMP-14, further this MMP-14 activates MMP-2
by binding with TIMP or EMMPRIN may directly acti-
vate MMP-2 through its fragment. The mechanism of
such activations is still not clearly understood, however
some theories have been proposed during the tumor
metastasis [58]. EMMPRIN exerts its effect through
direct cell-cell interaction in the tumor metastasis by
stimulating MMP production from nearby fibroblasts
[59]. It has been suggested that EMMPRIN serves as its
own counter-receptor in cancer cells thus stimulating
MMP production through homophilic interaction
between EMMPRIN molecules on opposing cells [60].
This hypothesis has been investigated in tumor cell pro-
gression but the situation in normal cells remains unclear.
Further studies are needed to clarify the regulatory role of
EMMPRIN in endometrial remodeling as a means of reg-
ulating the implantation process in non-invasive implan-
tation animals; ruminant.
Conclusions
In this study, EMMPRIN was differentially expressed in
endometrium including on feto-maternal interfaces.
Expression of EMMPRIN on feto-maternal interfaces
may facilitate adhesion and fusion of embryo to luminal
epithelium by directly itself through physiological tissues
Figure 7 Localization of MMP-1 and MMP-14 mRNA in the endo-
metrial tissues during the estrous cycle and early gestation. Sev-
en-micrometer sections of the endometrium were hybridized with DIG 
labeled antisense cRNA probes of MMP-1 (A-E) and sense cRNA probes 
(A'-E'). A, A': before ovulation (BOV); B, B': after ovulation (AOV); C, C': 
middle of estrous cycle (MEC); D, D': Day 19 of gestation; E, E': Day 30 of 
gestation. MMP-14 mRNA antisense (F-J) and sense cRNA probes (F'-J'). 
F, F': BOV; G, G': AOV; H, H': MEC; I, I': Day 19; J, J': Day 30 of gestation. 
Abbreviations are same as Figure 2. Scale bar = 20 μm (objective; 20×).Mishra et al. Reproductive Biology and Endocrinology 2010, 8:60
http://www.rbej.com/content/8/1/60
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remodeling and developmental process, and/or stimulat-
ing MMPs to compensate endometrial functions.
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